Article
IGF-1 and cardiometabolic diseases: a Mendelian randomisation study.
Diabetologia - 1 Sept 2020
Larsson Susanna C, Michaëlsson Karl, Burgess Stephen
Abstract excerpt
AIMS/HYPOTHESIS: Abnormal serum IGF-1 levels are associated with an increased risk of type 2 diabetes and cardiovascular disease. However, the causal role of IGF-1 levels within the normal range in cardiometabolic disease remains unclear. We employed Mendelian randomisation to explore the associations between genetically predicted serum IGF-1 levels and cardiometabolic diseases. METHODS: Serum IGF-1 levels were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
